Search by Drug Name or NDC

NDC 69238-1107-03 Tiagabine Hydrochloride 16 mg/1 Details

Tiagabine Hydrochloride 16 mg/1

Tiagabine Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is TIAGABINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Tiagabine is used in combination with other medications to treat partial seizures (a type of epilepsy). Tiagabine is in a class of medications called anticonvulsants. It is not known exactly how tiagabine works, but it increases the amount of natural chemicals in the brain that prevent seizure activity.

Related Packages: 69238-1107-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tiagabine

Product Information

NDC	69238-1107
Product ID	69238-1107_6365c695-acda-442b-aca2-7fb3d0961bc3
Associated GPIs	72170070100320
GCN Sequence Number	034739
GCN Sequence Number Description	tiagabine HCl TABLET 16 MG ORAL
HIC3	H4B
HIC3 Description	ANTICONVULSANTS
GCN	37982
HICL Sequence Number	015773
HICL Sequence Number Description	TIAGABINE HCL
Brand/Generic	Generic
Proprietary Name	Tiagabine Hydrochloride
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tiagabine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	16
Active Ingredient Units	mg/1
Substance Name	TIAGABINE HYDROCHLORIDE
Labeler Name	Amneal Pharmaceuticals NY LLC
Pharmaceutical Class	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA208181
Listing Certified Through	2025-12-31

Package

NDC 69238-1107-03 (69238110703)

Pricing Information	N/A
NDC Package Code	69238-1107-3
Billing NDC	69238110703
Package	30 TABLET in 1 BOTTLE (69238-1107-3)
Marketing Start Date	2017-12-08
NDC Exclude Flag	N